These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23073047)

  • 21. Late Hyporegenerative Anemia Following Successful Management of Rh-D Alloimmunization: Still an Underappreciated Entity.
    Thomsen WC; Afify ZA
    Clin Pediatr (Phila); 2021 Sep; 60(9-10):399-402. PubMed ID: 34098759
    [No Abstract]   [Full Text] [Related]  

  • 22. Intrauterine fetal transfusion.
    Mirghani HH; Weerasinghe S; Al-Awar S; Hamud OA
    Saudi Med J; 2004 Dec; 25(12):2001-3. PubMed ID: 15711685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Spectrophotometric characteristics of the amniotic fluid in Rh isoimmunization following intrauterine fetal blood transfusions].
    Matrova TS; Vasileva Iu
    Akush Ginekol (Sofiia); 1989; 28(1):30-2. PubMed ID: 2500862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anemia and edema in hemolytic disease of the newborn].
    Niedzicka E; Radomska I; Lozińska D
    Acta Haematol Pol; 1988; 19(1-2):65-70. PubMed ID: 2467500
    [No Abstract]   [Full Text] [Related]  

  • 25. Fetal and neonatal hematologic parameters in red cell alloimmunization: predicting the need for late neonatal transfusions.
    Saade GR; Moise KJ; Belfort MA; Hesketh DE; Carpenter RJ
    Fetal Diagn Ther; 1993; 8(3):161-4. PubMed ID: 8240686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perinatal management of fetal hemolytic disease due to Rh incompatibility combined with fetal alloimmune thrombocytopenia due to HPA-5b incompatibility.
    Schild RL; Hoch J; Plath H; Geissen C; Fahnenstich H; Dame C; Hansmann M
    Ultrasound Obstet Gynecol; 1999 Jul; 14(1):64-7. PubMed ID: 10461341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Maternal blood intrauterine transfusions in the therapy of red-cell alloimmunization performed in three difficult cases].
    Kucińska-Chahwan A; Massalska D; Bijok J; Rudzińska M; Kopeć I; Rzymkiewicz L; Jakiel G; Roszkowski T
    Ginekol Pol; 2014 Sep; 85(9):703-7. PubMed ID: 25322544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Specificity and incidence of erythrocyte antibodies in pregnant patients with intrauterine transfusions for fetal erythroblastosis].
    Hoch H; Giers G; Bald R; Hanfland P
    Beitr Infusionsther; 1992; 30():439-42. PubMed ID: 1284755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.
    Gupte SC; Lulla CP; Kulkarni SS; Korgaonkar SA; Walvekar VR; Merchant RH
    J Matern Fetal Med; 1998; 7(6):287-91. PubMed ID: 9848694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness of the treatment of severe cases of fetal erythroblastosis by intrauterine blood transfusion].
    Lukaszewicz E; Korzycki J; Debski R; Ciastoń W; Falecka K; Latoszewska W; Marianowski L
    Acta Haematol Pol; 1988; 19(3-4):212-6. PubMed ID: 3150897
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful treatment of neonatal rhesus hemolytic anemia with high doses of recombinant human erythropoietin.
    Wacker P; Ozsahin H; Stelling MJ; Humbert J
    Pediatr Hematol Oncol; 2001 Jun; 18(4):279-82. PubMed ID: 11400653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between two treatment protocols with recombinant human erythropoietin (rHuEpo) in the treatment of late anemia in neonates with Rh-isoimmunization.
    Zuppa AA; Alighieri G; Fracchiolla A; Catenazzi P; D'Antuono A; Riccardi R; Cavani M; Romagnoli C
    Pediatr Med Chir; 2012; 34(4):186-91. PubMed ID: 23173411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe Rh(D) immunization: anti-D quantitation and treatment possibilities during pregnancy and after birth.
    Gottvall T; Hildén JO; Nelson N; Filbey D
    Acta Paediatr; 1995 Nov; 84(11):1315-7. PubMed ID: 8580635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.
    Rath ME; Smits-Wintjens VE; Lindenburg IT; Folman CC; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
    Transfusion; 2013 Jul; 53(7):1580-5. PubMed ID: 23113703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rh hemolytic disease of the newborn.
    Page S
    Neonatal Netw; 1989 Jun; 7(6):31-41. PubMed ID: 2499756
    [No Abstract]   [Full Text] [Related]  

  • 36. [Rh alloimmunization].
    Boda D; Pataki L
    Orv Hetil; 1996 Nov; 137(44):2485. PubMed ID: 9026764
    [No Abstract]   [Full Text] [Related]  

  • 37. Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions.
    Scheier M; Hernandez-Andrade E; Fonseca EB; Nicolaides KH
    Am J Obstet Gynecol; 2006 Dec; 195(6):1550-6. PubMed ID: 16796991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Critical comments on the current treatment of neonatal hemolytic diseases due to anti-Rh(D) isoimmunization].
    Velcovici D; Grigoriu G
    Rev Pediatr Obstet Ginecol Pediatr; 1986; 35(4):345-59. PubMed ID: 3105027
    [No Abstract]   [Full Text] [Related]  

  • 39. Albumin and packed red blood cells in the treatment of severely isoimmunised pregnancies.
    Marianowski L; Debski R; Rokicki T; Pasek K; Lukaszewicz E; Gromadzki J
    Mater Med Pol; 1992; 24(4):260-1. PubMed ID: 1308057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhesus immunization: new perspectives in maternal-fetal medicine.
    Stangenberg M; Selbing A; Lingman G; Westgren M
    Obstet Gynecol Surv; 1991 Apr; 46(4):189-95. PubMed ID: 1902926
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.